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Purpose: Adipose stem cells (ASCs) represent a reliable source of stem cells with a 
widely demonstrated potential in regenerative medicine and tissue engineering 
applications. New recent insights suggest that three-dimensional (3D) models may 
closely mimic the native tissue properties; spheroids from adipose derived stem cells 
(S-ASCs) exhibit enhanced regenerative abilities compared with those of 2D models. 
Stem cell therapy success is determined by “cell-quality”; for this reason, microRNA 
profiles, the involvement of stress signals and cellular aging need to be further 
investigated. 
Material and Methods: Adipose tissue was collected from healthy individuals, 44 
females and 17 males, after signing informed consent.  Mean age was 50, 25 years 
(range: 18-77). Lipoaspirate samples were harvested from different body areas such as 
abdomen, breast, flanks, trochanteric region, and knee. Here, we performed a 
comparative analysis, molecular and functional, of miRNA expression pattern  profile 
“stemness and differentiation associated”, genes connected with stemness, aging, 
telomeric length and oxidative stress, of   adipose stem cells in three-dimensional  and 
adhesion conditions,  SASCs-3D and ASCs-2D cultures.  
Results: We have demonstrated that Spheroids from Adipose-derived Stem Cells 
(SASCs-3D) present express high level of the typical miRNAs and mRNAs of iPS cells, 
such as miR-142-3p and SOX2/POU5F1/NANOG, in canonical and in long term in 
vitro culture condition, express low level of the early and late miRNAs and mRNAs 
typical of chondrocytic, adipocytic and osteoblastic lineages in canonical and in long 
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term in vitro culture condition. The expression levels of stemness-related markers and 
anti-aging Sirtuin1 were significantly up-regulated (P < 0.001) in SASC-3D while gene 
expression of aging-related p16INK4a was increased in ASCs-2D (P < 0.001). We 
found that  3D and 2D cultures also presented a different gene expression profile for 
those genes related to telomere maintenance (Shelterin complex, RNA Binding proteins 
and DNA repair genes) (P < 0.01 and P < 0.001) and oxidative stress (aldehyde 
dehydrogenase class1 and 3) (P < 0.05, P < 0.01 and P < 0.001) and presented a striking 
large variation in their cellular redox state. 
Conclusion: Based on our findings, we propose a “cell quality” model of SASCs, 
highlighting a precise molecular expression of microRNA pattern profiles, several 
genes involved with stemness (SOX2, POU5F1 and NANOG), anti-aging (SIRT1), 











Recently, in the field of oncology, stem cell biology, and tissue engineering, the 
scientific community has considered artificial two-dimensional cell cultures, as cells 
express their specific-tissue characteristics only when they reside within a "niche" 3D 
micro-environment as in vivo. It has been shown that cells lose tissue specificity when 
they are separated from the niche but through many different techniques can be possible 
to re-establish the three-dimensionality and cell-cell contacts.  Cells in a three-
dimensional environment give rise to aggregates in suspension, the so-called 
"spheroids"  (Mueller-Klieser, 1997). In the last few years, different techniques have 
been developed for spheroid isolation but the term “spheroids” cannot be associated to 
a unique conceptual biological identity. For this reason, further molecular investigations 
are needed to clearly define the biological characteristics of such spheroids. The 
principal methods for the isolation of spheroids are spinner flasks, hanging-drop, 
coated-supports  (Iwai et al., 2016). A recent study has shown that it is possible to 
differently obtain Spheroids from Adipose derived Stem Cells (S-ASCs) in suspension 
directly from lipo-aspirated samples when the Stromal Vascular Fraction (SVF) portion 
is cultured with serum free and ultralow-adhesion conditions ((Di Stefano AB 2015). 
We tried to answer the question of whether real stem cells are those in suspension (3D) 
or adhesion (2D). Furthermore, we wanted to better understand if the application of S-
ASCs could be a feasible strategy in various fields of regenerative medicine. To do this, 
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a deeper molecular characterization will be required, from genotypic and phenotypic 
analysis to determine and highlight specific targets that specifically identify adipose 









1.1 Stem Cell History  
In 1909 Alexander A. Maximow was the first to discuss about stem cells on a text 
entitled "The lymphocyte as a stem cell, common cells to different blood elements in 
embryonic development and during the post-fetal life of mammals." The term "stem" 
(ie stem, trunk), has found diffusion thanks to “On the Origin of Species” by C.Darwin, 
and subsequently thanks to Haeckel, who associated with the term "stammzelle"  both 
the single-cell organism (parent of all species), both the fertilized egg cell  (Ramalho-
Santos and Willenbring, 2007). In the following decades, the term “stem” continued to 
be used in  embryological studies (Maehle, 2011), as well as in haematology 
(Pappenheim and A., 1907), and histology, giving  multiple connotation in different 
contexts: of development, reproduction and differentiation. At the same time, tumor 
pathogenesis studies have indicated as causative agent of cancer a group of embryonic 
cells called "embryonic rudiment", who had remained in the adult organism by mistake 
(Cohnheim and J, 1877). Until the first half of the twentieth century, therefore, the term 
"stammzellen" has maintained a double meaning: the first of normal development and 
the second as a causative factor of diseases. In 1978 hematopoietic stem cells were 
discovered in the human umbilical cord, twenty years later it was discovered they had 
an important role in leukemia, therefore there was the first association between stem 
10 
 
cells and cancer. 
 
1.2 Main Features 
The stem cell is a non-specialized immature cell from which it can originate a single 
tissue, multiple tissues or the whole organism. It must have two characteristics: 
- Self-renewal, i.e. a mother cell gives rise to two identical daughter cells, by 
symmetrical division or by asymmetric division in which one of the two daughter cells 
undertakes a differentiation path  (BECKER et al., 1963), . 
- Differentiation potential, or the ability that a cell possesses to specialize towards a 
tissue line through genetic and protein modifications. 
Stem cells are classified according to their differentiation capacity: 
• Totipotency: totipotent cell called zygote gives rise to the whole organism including 
the extra-embryonic appendages (trophoblast and placenta)  
• Pluripotency: pluripotent cell gives rise to the three embryonic sheets, endoderm, 
mesoderm and ectoderm, but is unable to generate the whole organism  
• Multipotency: multipotent cell gives rise to only specific tissues, for example 
hematopoietic stem cells are able to generate only blood cells. These cells are called 
adult because they are found only in adult and non-embryonic tissues.  
• Unipotency: unipotent cell is able to differentiate into a single histological type.  
  
1.3 Source of stem cells 
Stem cells are further classified according to their origin into: 
- Embryonic cells, are pluripotent at the blastocyst stage. Their use in research is 
prohibited in most countries for religious, ethical and political reasons. 
- Fetal cells, obtained from embryonic tissues in advanced stages, and from fetal tissues, 
blood, bone marrow, etc. 
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- Stem cells of embryonic adnexa: obtained from the umbilical cord, placenta and 
amniotic sac. 
- Adult stem cells: they are multipotent or unipotent cells, essential for the cellular 
homeostasis of adult tissues, they have no limitations and they are used for clinical 
purposes.  
 
1.4 Mesenchymal stem cells (MSCs) 
Mesenchymal stem cells (MSCs) are adult multipotent cells present in the mesenchyme 
of many tissues such as: bone marrow (Majumdar et al., 1998), adipose tissue (Zuk et 
al., 2002), placenta (In 't Anker et al., 2004), umbilical cord blood (0848804) and dental 
pulp (Gronthos et al., 2000). Mesenchyma is a ubiquitous tissue with a regulatory and 
structural function that originates from mesodermal sheet. In the 1970s, Friedestein and 
colleagues isolated very rapidly proliferating fibroblast-like cells from the bone marrow  
(Friedenstein et al., 1976). Currently it has been shown that MSCs, in addition to 
differentiating into tissues of mesodermal origin, can also differentiate into cells of 
ectodermal and endodermal tissues such as epithelial cells, cells of the digestive system, 
liver and lung (Jiang et al., 2002), (Kotton et al., 2001)).  
 
1.5 Bone Marrow Mesenchymal Stem Cells (BM-MSCs) 
Hematopoiesis have shown the presence of a different population of stem cells in 
addition to hematopoietic stem cells, localized in the stroma. In vitro, the BM-MSCs 
have been isolated and separated from hematopoietic cells thanks to their ability to 
adhering to the substrate. Flow cytometric analysis showed the presence of the 
membrane markers CD105 (SH2), CD73 (SH3 / 4), ICAM-1 (intercellular adhesion 
molecules), CD29  (Haynesworth et al., 1992), (Conget and Minguell, 1999),  (Le Blanc 
et al., 2003) and the absence of CD45 , CD34, CD14 or CD11. However, although BM- 
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MSCs play a fundamental role in organogenesis, remodeling and tissue repair, but their 
use has several disadvantages; drawing bone marrow from iliac crest is painful, invasive 
and hazardous (Bianco, 2011),  volume obtained under local anesthesia is about 40 ml, 
for larger volumes total anesthesia is required. In addiction the mesenchymal 
component is a small fraction of the total bone marrow cell population. 
 
1.6 Adipose derived stem cells (ASCs) 
In regenerative medicine, specific requirements must be satisfied to obtain application 
benefits. Gimble et al, list the main requirements (Gimble et al., 2007): 
- be available in large quantities (billions of cells),  
- be collected using minimally invasive techniques,  
- be able to differentiate in different cell lines in a reproducible way, 
- be treated according to current guidelines. 
About this, adipose tissue possesses the requisites listed above,  it is homogeneously 
distributed along the body surface, representing 10-30% of the weight of a healthy 
person. Its physiological abundance and its easy surgical accessibility have defined it, 
in recent years, the new primary source of mesenchymal cells (Zuk et al., 2002). 
Adipose tissue derives from mesodermal sheet and is made up of adipocytes (the largest 
share) and the vascular stromal fraction (SVF), a heterogeneous population composed 
of preadipocytes, fibroblasts, smooth muscle vessel cells, leukocytes and adipose stem 
cells (Weisberg et al., 2003).  Flow cytometric analysis showed the presence of the 
membrane markers  such as CD271, CD90 (Thy-1) , CD105 or endoglin; CD29 or β-
subunit of the fibronectin receptor, CD44 or receptor III of the extracellular matrix and 
CD73 or SH3-SH4 (Majumdar et al., 2003) and the lack of typical antigens of the 
hematopoietic lineage, such as CD45 or CD34. It is known that the molecular pathways 
of stem cells are controlled both by changes in gene expression, mechanisms to activate 
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or repress transcription of specific groups of genes, both epigenetic and post-
trascriptional modifications. Recently, transcription factors involved in the regulation 
of the pluripotency state, such as Nanog, Oct-4 and SOX-2, have been investigated. 
They play a central role in maintaining ESC self-renewal, expressing similar regulatory 
roles in multipotent MSCs (Jaenisch and Young, 2008), (Pierantozzi et al., 2011). 
Differentiations towards mesenchymal lines are multi-step processes of molecular and 
functional modifications that occur in the presence of certain substances. About 
adipocyte lineage, the culture media must contain insulin, IGF-1, triiodiothyronine and 
transferrin (Deslex et al., 1987), as well as hydrocortisone or dexamethasone. After a 
short period there is a gradual accumulation of droplets containing triglycerides, various 
molecules such as the lipoprotein lipase (LPL) and the activated receptor gamma 
peroxisome proliferator (PPAR-gamma or PPARG). Osteoblastic differentiation is a 
multi-step process mediated by ascorbic acid, vitamin D3 glucorticoids or bone 
morphogenic proteins (BMP) (Zhou et al., 2004), typical markers of osteoblastic 
differentiation are osteopontin (OPN), alkaline phosphatase (ALP) or RUNX family 
transcription factor 2    (RUNX2)  (Halvorsen et al., 2001). In the extracellular matrix, 
calcium phosphate minerals accumulate, detectable by von Kossa staining. 
Chondrogenic differentiation requires ascorbic acid, dexamethasone and TGFb1, SOX9 
and Col10A, typical  differentiation markers, are expressed after a few days of 
incubation (Koga et al., 2009). The synthesized hyaluronic acid is detectable by the 
alcian blue assay. 
 
1.7 Spheroids of adipose derived stem cells (S-ASCs) 
Two‐dimensional (2D) cell cultures are a very useful tool to perform in vitro studies 
and experiments in the field of oncology, stem cell biology, and tissue engineering, but 
it has been recently questioned whether they properly represent the original tissue. This 
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is leading to a progressive replacement of 2D cultures in favour of three-dimensional 
(3D) cell cultures. While cells grown in monolayer lose their tissue specificity, 3D 
cultures show patterns of protein expression and intercellular junctions that are more 
faithful to conditions in vivo and therefore are a very attractive system for the scientific 
community. (Abbott, 2003). Even though cells lose their structural characteristics when 
they are separated from which they originate, there are different techniques that enable 
one to re-establish three‐dimensionality and cell–cell contacts. A 3D environment 
stimulates cells to grow in suspended aggregates that are defined as “spheroids” (Di 
Stefano AB 2015), there are several method to obtain them, such as the spinner flasks  
(Mueller-Klieser, 1987), hanging‐drop  (Naderi et al., 2014) , and coated‐supports  (Iwai 
et al., 2016) techniques. Di Stefano et al,  developed a technique for the isolation of 
spheroids of adipose stem cells (SASCs) from freshly processed tissue implementing a 
direct in vitro spheroid culture method that maintain stemness properties in 3D 
conditions and also, shown SASCs, with this method, express specific mesenchymal 
stem cell (MSC) (e.g. CD29, CD9, CD73, CD90, and CD271) and display enhanced 
ability to differentiate towards MSCs lineages  (Di Stefano AB 2015). 
 
1.8 “Small regulatory RNA” MicroRNA 
MiRNAs are endogenous small noncoding RNAs involved in the regulation of several 
biological pathways, and they could have a critical role in regulating self‐renewal and 
MSC differentiation (Kang and Hata, 2015). MicroRNAs have been discovered in 
different points of the genome, 50% of them are intragenic, both at the intronic level, 
both at the exon-intron level, and on the complementary strand. The remainder is found 
within non-coding intergenic sequences. The microRNAs are transcribed by RNA 
Polymerase II, the first transcript, called pri-miRna, consists of 100-100bp and has a 
stem and loop shape with a cap to 5'P and a poly-Adenine tail to 3'OH, the maturation 
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process has two steps: Cropping (nuclear process) -> pre-miRna composed of about 70 
bp maintains the stem and loop shape with 2-3 nt protruding single helix at the 3'OH 
end and Dicing (cytoplasmatic process) that formed final double-stranded miRna of 18-
22 nt. Between two filaments, only one plays its role, called “guide”, the other called 
"passenger" is degraded. Due to their small size, a miRNA is complementary to the 
3'UTR ranges of different messengers and vice versa, i.e. the same messenger can be 
the target of different miRNAs that recognize different positions of the 3'UTR region. 
Over the years several algorithms have been developed, the best known are: Diana-
microT, Miranda, MiRtarbase, TARGETMINER, TARGETSCAN-VERT, PICTAR-




1.9 Adipose Tissue: the role of microRNAs 
Differentiation of MSCs into specific types of mature cells is regulated by a complex 
system where growth factors, transcription factors, and signalling pathways play a 
crucial role. Recent evidence report that microRNAs (miRNAs) are actively involved 
in regulating cell stemness through a negative, post-transcriptional, gene expression 
regulation (Ambros, 2004) (Bartel, 2009). Recent studies have shown that miRNAs 
play an important role on the proliferation and differentiation of adipose stem cells 
through the modulation of various factors such as receptors or ligands. Numerous 
pathways implicated in mesenchymal differentiation of ASCs are modulated by 
miRNAs, including the Bone Morphogenetic Protein (BMP), small mother against 
decapentaplegic (SMAD), and WNT pathway. In this regard, the BMP signalling 
pathway has been seen to be modulated by miR-125b, or the SMAD1 protein is found 
to be down-regulated, by miR-199. Several miRNAs regulate the WNT pathway, in 
particular, miR-29 which targets some antagonist molecules of the Wnt pathway such 
as Dkk1, Kremen2 and sFRP2  (Chen et al., 2014). miR-142-3p and miR-25 contribute 
to maintaining stemness, miR‐142‐3p seems to play a crucial role in maintaining iPSC 
immaturity (Abdul Razak et al., 2014) and thus it can be considered a stemness marker. 
The latter is associated with an indirect modulation of Yamanaka factors through the 
regulation of some factors like WWP2, fbxw7 (Lu et al., 2012).  
 
1.10 Long Term in vitro culture and replicative senescence 
In regenerative medicine, maintenance of stem cell properties is crucial. Aging is 
considered to be the cause of the decrease in stem cell potential. Human mesenchymal 
stem cells (hMSCs) are expanded in vitro before implantation. However, the 
relationship between stem cell expansion and genetic stability is poorly understood. All 
primary human cells, including hMSCs, undergo only limited number of cell divisions 
17 
 
under standard culture conditions, in a process called cellular replicative senescence  
(HAYFLICK and MOORHEAD, 1961). MSCs become senescent during prolonged 
"long-term culture", as indicated by their reduced differentiation potential, shortening 
of the mean telomere length and morphological alterations  (Izadpanah et al., 2006), 
(Bonab et al., 2006). Traditional adherent cells do not grow in serum-free conditions 
and are therefore susceptible to cell aging, modifying their genetic and protein 
structures during the long-term in vitro culture condition (Zhao et al., 2015). The cell 
cycle is a process that embodies the central dogma of molecular biology. It is a 
genetically controlled process, consisting of a series of coordinated and mutually 
dependent events on which the correct proliferation of eukaryotic cells depends (Israels 
and Israels, 2001). Primary somatic mammalian cells can replicate approximately 50 
cumulative doublings in vitro, after which the cells stop dividing (HAYFLICK and 
MOORHEAD, 1961). Before Leonard Hayflick's discovery, it was believed that cells 
divide indefinitely. Hayflick demonstrated  fibroblasts, isolated from individuals, have 
a limited proliferative capacity in vitro (Hayflick, 1965). After n-cycles of replication 
they enter in a state called senescence. It is assumed  there is an internal clock capable 
of both counting the number of divisions and blocking proliferation once the 
predetermined threshold of possible divisions has been reached. It is well-known that 
life span of MSCs is limited, and that during in vitro culture they lose differentiation 
potential and progress to replicative senescence  (Trivanović et al., 2015), (Allsopp et 
al., 1992) (Stewart and Weinberg, 2006). 
 
 
1.11 Cellular Aging 
Aging (see Glossary) is a gradual deterioration of physiological functions leading to 
reduced fitness, increased susceptibility to pathologies and increased mortality rate. 
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Cancer, diabetes, cardiovascular disorders, immune decay and neurodegenerative 
diseases are among the main ageing-associated pathologies. These phenotypes refer to 
cellular and molecular changes (Sames, 2005) which defined aging as "the sum of the 
primary restrictions in the regenerative mechanisms of multicellular organisms". 
Campisi 2000 associates the term aging with Hayflick's concept of replicative 
senescence, defining it as "a substantially irreversible arrest of cell division" (Campisi, 
2000). Therefore senescent cells, unlike apoptotic ones, are alive but with functional 
imbalances (Itahana et al., 2001). In general, senescent cells exhibit enlarged and 
flattened morphology and are blocked in G1 phase, meaning genes that drive cell cycle 
progression are repressed and cell cycle inhibitors such as p53 / p21 and p16 / RB are 
up-regulated. Increased cell size is often associated with senescence condition  (Dimri 
et al., 1995),  in vitro MSCs aged  are larger (Baxter et al., 2004), (Mauney et al., 2004) 
compared to their younger counterparts; exhibit more podiums and contain more actin 
stress fibers (Stenderup et al., 2003). Senescent cells show altered gene and biochemical 
processes, (SIRT1) is an NAD1-dependent lysine deacetylase involved in regulating 
various cellular processes, including cellular senescence, bone homeostasis, and 
metabolic pathways, SIRT1 contributes to long-term growth through the delay of 
senescence during prolonged cell passages (Yuan et al., 2012). In  absence of SIRT1, 
MSCs prematurely lose their capacity for self-renewal and show an up-regulation of 
cell cycle inhibitors, anticipating replicative senescence (Yoon et al., 2014). Yoon et al 
demonstrated that SIRT1 deacetylase positively regulate the SOX2 expression in the 
bone marrow-MSCs (BM-MSCs), which is consequently overexpressed. SIRT1 
decreases during differentiation processes, regulates osteoblastic differentiation process 
by deacetylating b-catenin and Runx2  (Simic et al., 2013), (Shakibaei et al., 2012). 
CDKN2A, also called p16INK4,  is a small ankyrin-repeat protein of 16 kDa encoded 
by INK4a in the INK4/ INK4a ARF locus, has emerged in the past 10 years as a valuable 
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candidate biomarker, is a key effector of cell senescence (Sorrentino et al., 2014),  
(Serrano et al., 1995) has been previously associated to senescence and apoptosis 
(Martin et al., 2014). p16 inhibits and  binds to  the cyclin-dependent kinases CDK4 
and CDK6, inducing cell cycle arrest in G1 (Serrano et al., 1993). Notably, the 
expression of this gene is reported to increase as mesenchymal stem cells age and 
undergo senescence (Burrow et al., 2017). However, these studies show that increased 
p16INK4a expression upon ageing causes loss of self-renewal capacity in multiple 
tissues. Therefore it is considered an important pro-aging marker, as its expression is a 
reflection of the metabolic and physiological state of  cells . 
 
1.12 Telomere, Sheltering Complex and Telomerase 
Telomeres are nucleoprotein complexes located in the terminal portions of 
chromosomes and consist of species-specific, non-coding and highly repeated 
sequences in tandem, associated with different proteins  (Sugimoto, 2010),  (Sethe et 
al., 2006). The 3 'and 5' ends of  the DNA double strands are extremely susceptible to 
nuclease degradation, and highly subject to genic fusion and recombination phenomena  
(Haber and Thorburn, 1984).Telomeres act as a protective "cap"of linear chromosomes 
preventing progressive degradation of DNA and conferring genetic stability. 
Furthermore, telomeres regulate the recognition and separation of chromosomes during 
mitosis, facilitate DNA replication positioning and anchoring chromosomes to the 
nuclear machinery (Blackburn, 1991), and influence the transcription of genes near to  
chromosomal ends. “The end replication problem”, first described by Watson in 1972, 
concerns the synthesis mechanism of the ends of linear chromosomes. DNA polymerase 
is unable to replicate the 5 'ends of the lagging strand. The DNA polymerase is capable 
of proceeding only in the 5'→ 3' direction so, while the guide strand (3'→5' leading 
strand) is synthesized entirely and continuously, the slow strand (5' → 3' lagging strand) 
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is synthesized in a discontinuous way starting from small RNA primers, capable of 
provide to DNA polymerase the "primer 3’OH”.  OKAZAKY’s small fragments are 
linked each other by DNA ligases. The problem occurs when at the distal end of the 
lagging filament,  DNase removes the 3'OH primer, its degradation leaves a gap at the 
5 'end which is thus shorter than the 3' end of 50-100 base pairs (Levy et al., 1992).  For 
this reason, at each cell division cycle, telomeres shorten up to the Hayflick limit 
(minimum critical length) which signals the onset of replicative senescence. In humans, 
telomeric DNA consists of nucleotide sequences 5'-TTAGGG-3 'in the leading strand 
and 3'-CCCTAA-5' in the lagging strand, repeated for approximately 9-15 kb (Moyzis 
et al., 1988). The 3 'end of the leading filament ends with single-stranded 50-300 G (G-
strand overhang)  (Zhu et al., 2011). The protruding strand of G folds into a loop and 
slips into the double helix of telomeric DNA, which in turn opens to form a triple helix 
structure called the D-loop (displacement loop, minor loop), the larger loop generated 
by the folding of the "protruding ends it is defined T-loop (telomere loop) (Figure 1B) 
(de Lange, 2005), (O'Sullivan and Karlseder, 2010). “Shelterin Complex”, is a multi-
protein complex, TRF1, TRF2, TIN2, RAP1, TPP1 and POT1, involved in the 
formation and maintenance of telomere architecture and in the regulation of their length 
(Figure 1B). Shelterin complex binds to the TTAGGG nucleotide sequence, stabilizes 
and protects the ends of chromosomes by mediating the formation of the T-loop (de 
Lange, 2005). It is difficult to have a clear picture of each function of Shelterin 
components, for example many in vitro studies have shown that TRF1 determine the T-
loop conformation (telomeric repeated binding factor 1) and TRF2 (repeated binding 
factor TTAGGG) favors the insertion of the G-strand overhang into the telomeric 
dsDNA, protecting it from mechanisms of repair, degradation, recombination and 
fusion (Burge et al., 2006), (van Steensel et al., 1998). TRF1 protein appears to be 
involved in  regulation of telomere length (van Steensel and de Lange, 1997) and TRF2 
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protein hinders the fusion of chromosomal ends and increases their stability (Broccoli 
et al., 1997).TRF2 also interacts MRE11 (Meiotic Recombination-11) complex, 
composed of MRE11, Rad50, and the NBS1 (Nijmegen Breakage Syndrome-1) protein, 
which is implicated in the cellular response to agents that damage DNA, localizes to the 
telomere. TERF2IP (Repressor / Activator Protein 1) is a TERF2 associated protein, 
protects telomeres from NHEJ, (Non-homologous End-joining) a DNA repair 
mechanism, acts as a transcription regulator when associated with TERF2 or other 
factors (Nandakumar and Cech, 2013),  (Martínez and Blasco, 2018),  and also has a 
stabilizing function (Sfeir, 2012). POT1 (Telomere Protection 1) possesses high  
affinity for the single-stranded TTAGGG region of telomeric DNA (Patel et al., 2015), 
protecting  it from the action of nucleases (Greider, 1999). TPP1 is a POT1 associated 
protein, loss of TPP1 leads to reduced POT1 function (Červenák et al., 2017) when 
telomeres need to be elongated, TPP1 is involved in telomerase recruitment (Bejarano 
et al., 2017). TIN2 (nuclear protein 2 interacting with TRF1 and TRF2) is a stabilizing 
protein, acts as a bridge between the units attached to the double stranded DNA, TRF1 
and TRF2, and the units attached to the single stranded DNA TPP1-POT1 (Méndez-
Pertuz et al., 2017). Telomerase is an enzyme, a telomere-specific reverse transcriptase, 
which adds telomeric repeats (5'-TTAGGG-3) to the ends of linear chromosomes, 
ensuring their integrity. Telomerase is composed by different proteins, in particular a 
catalytic subunit with reverse transcriptase function (Telomerase Reverse 
Transcriptase, TERT) synthesizes DNA from RNA, and  RNA component (Telomerase 
RNA Component, TERC or TR) which acts as   a template (Autexier and Lue, 2006), 
(Wenz et al., 2001)). In normal somatic cells, telomere sequences are lost during 
replication in vitro and in vivo due to  “The end replication problem" phenomenon 
(Bodnar et al., 1998), (Martens et al., 2000). In contrast, cancer cells,  immortalized 
cells and  embryonic stem cells bypass the  end replication problem thanks to reverse 
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transcriptase activity (Kim et al., 1994), (Amit et al., 2000). Unlike most adult somatic 
cells that are telomerase negative, mild and moderate activity of the enzyme, has 
described in multipotent stem cells. There are conflicting opinions regarding the 
proliferative capacity of multipotent, for many telomerase activity has not been detected 
in multipotent stem cells (Zimmermann et al., 2003), for the others such as Pittenger et 
al, MSCs possess a moderate  active telomerase  (Pittenger et al., 1999). 
 
 
1.13 Oxidative stress and  micro cellular environment 
The term oxidative stress indicates a state of alteration of macromolecules into cells and 
tissues when these are exposed to an excess of oxidizing agents (McCord, 2000). In all 
aerobic organisms there is a delicate balance, called redox, between the production of 
oxidizing substances, including reactive oxygen species (ROS), and the antioxidant 
defence system that has the task of preventing and / or repairing possible damage 
produced. ROS, free radicals centred on oxygen, are the main by-products formed in 
the cells of aerobic organisms (Rahman, 2007), more precisely, they initiate dangerous 
autocatalytic chain reactions. The main targets of ROS are  phospholipid components 
of bio-membranes and plasma lipoproteins (Halliwell and Gutteridge, 1990),  
(Kowaltowski and Vercesi, 1999). To be attacked are mainly the polyunsaturated fatty 
acids (PUFA), which undergo a chain process, known as lipid peroxidation, which 
involves their transformation into lipid hydroperoxides (LOOH) and secondary 
aldehyde compounds, such as malondialdehyde (MDA) and 4-hydroxinonal (4-HNE). 
Aldehydes, and their associated toxicity, are involved in many pathological processes 
including neurodegenerative diseases, cancer etc. (Yoritaka et al., 1996).  The aldehyde 
dehydrogenase (ALDH) superfamily is represented in all three taxonomic domains 
(Archaea, Eubacteria and Eukarya), it represents a significant metabolic pathway of the 
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aldehyde detoxification, it oxidizes aldehydes to carboxylic acids. The human genome 
contains 19 ALDH genes, mutations in which are the basis of several diseases. In 
particular, members of the ALDH 3 family (ALDH3A1, ALDH3A2, ALDH 3B1 and 
ALDH 3B2) appear to have unique roles in cellular defence against oxidative stress and 
aldehyde toxicity (Marchitti et al., 2010). 
 
1.14 ROS and ALDH  in adipose stem cells 
The intracellular redox environment critically affects all major cellular processes, such 
as proliferation, self-renewal, apoptosis, senescence and differentiation; any alteration 
of these processes, in mesenchymal stem cells, determines their malfunction. Some 
reports demonstrated that MSCs cultured under hypoxia showed a diminished capacity 
to differentiate into adipocytes and osteocytes, supporting the notion that low oxygen 
tension promotes an undifferentiated state (Müller et al., 2011), (Holzwarth et al., 2010). 
In particular,  excessive production of reactive oxygen species (ROS) compromises the 
redox homeostasis of stem cells, which leads to serious dysfunctions such as replicative 
senescence and loss of stem properties during long-term in vitro culture (Liang and 
Ghaffari, 2014), (Holmström and Finkel, 2014) ]. Furthermore, ASCs have been shown 
to accumulate ROS during adhesion expansion in vitro (Suh and Lee, 2017). Under 
physiological conditions, stem cells keep ROS levels low to preserve their stemness and 
continue to be functional, remain quiescent in mammals (Holmström and Finkel, 2014), 
(Shi et al., 2012). ALDH family is one of the most important family of enzymes that 
impart resistance to oxidative stress on MSCs. High ALDH activity is one of the 
attributes of many stem cells and contributes significantly to cell survival, i.e. through 
the ability to eliminate toxic and xenobiotic aldehydes in humans (Balber, 2011). They 
are involved in a variety of important stem cell functions including regulation of self-
renewal ability, differentiation potential, and oxidative stress response, cellular 
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expansion (Muramoto et al., 2010), (Zhou et al., 2015), (Tomita et al., 2016), (Balber, 
2011) In Najar's work, they have used the fluorescence-activated cell sorting (FACS) 
technology to isolate ASC sub-populations based on their ALDH activity. They have 
obtained ASCs with a different enzymatic activity of ADLH, ALDH⁺, and ALDHˉ. 
Results showed that ALDH⁺ ASCs demonstrated a more significant increased 
expression of proliferation genes, in particular  High ALDH3A1 expression. In general, 
they proposed ALDHs as stemness markers, but also as self-protection, immunity, 
differentiation markers (Najar et al., 2018).  
 
1.15 TGF-ß Cytokine in stem cells 
TGF-ß plays a key role in cell differentiation and proliferation especially in stem cells. 
Proteins of the TGF-ß family play an essential role in maintaining the pluripotency of 
human ESCs (James et al., 2005). The same is true for multipotent stem cells, TGF-ß  
produced in an autocrine way, or by factors in their microenvironment. The TGF-ß 
family is encoded by 33 genes. TGF-ß family ligands include TGF-ßs, activins, nodals, 
"growth and differentiation factors" (GDF) and bone morphogenetic proteins (BMPs) 
(Shi and Massagué, 2003). In human MSCs, proliferation is stimulated by Wnt or TGF-
ß signaling (Boland et al., 2004),  (Jian et al., 2006). TGF-ß1 induces Smad3-dependent 
nuclear accumulation of ß-catenin in MSCs, which is required for cell proliferation. 
TGF-β also plays an important role in MSC differentiation (Roelen and Dijke, 2003). 
For example, BMPs induce the differentiation of mesenchymal cells into chondroblasts 
or osteoblasts in vitro. TGF-β and activin are required in the differentiation of 
chondroblasts in the early stages. 
 
1.16 Rationale and Objectives 
Recently our group research has demonstrated spheroids from ASCs (S‐ASCs) can be 
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directly obtained from lipo‐aspirated samples, using the stromal vascular fraction (SVF) 
portion cultured in serum‐free and ultra low‐adhesion conditions. Thus, we have further 
genotyped and phenotyped this cell population in vitro and in vivo, demonstrating S‐
ASCs express typical MSC markers, such as CD29, CD44, CD9, CD73, CD90, and 
CD271. Moreover, S‐ASCs show more stemness properties than ASCs, as 
demonstrated by the higher expression of stemness‐associated messengers RNA 
(mRNA). Accordingly, S‐ASCs express a lower level of mesenchymal differentiation 
marker such as bone morphogenetic protein. We have also investigated their 
regenerative potential in animal models, reporting that cells grown on scaffold, such  as 
Integra  (Di Stefano et al., 2020b) , and afterward implanted in a laminectomy site are 
able to actively participate in bone tissue regeneration  (Di Stefano AB 2015) . 
The main aim of this project is to answer the fateful question whether real stem cells 
are those in suspension (3D) or in adhesion (2D). Moreover, if S-ASCs application 
could be a feasible strategy in various fields of regenerative medicine, from bone or 
tendons lesions, nervous or endothelial (vascular) regeneration. To do this, a deeper 
molecular characterization will be needed, from genotypic and phenotypic analysis to 
determine and highlight specific targets that specifically identify the adipose stem cells 
in a lipoaspirate samples.  
For that purpose, we compared 2D versus 3D cultures  analyzing: 
- Morphology and viability tests; 
- microRNAs profiling and focusing on mRNAs involved in stemness maintenance and 
mesenchymal differentiation at different time points of culture; 
- telomere length, telomerase activity, aging; 
- oxidative environment and redox homeostasis; 






Materials and Methods 
 
 
2.1 Adipose Tissue Patients 
Adipose tissue was collected from healthy individuals, 44 females and 17 males, after 
signing informed consent at the Department of Plastic and Reconstructive Surgery of 
the University Hospital of Palermo.  Mean age was 50, 25 years (range: 18-77). The 
hospital ethical committee approved the study, and from each patient an informed 
consent was collected. Lipoaspirate samples were harvested from different body areas 
such as abdomen, breast, flanks, trochanteric region, and knee. 
2.2 Cell culture  
Lipoaspirate samples were digested with collagenase (150 mg/ml; Gibco, Carlsbad, 
CA) through gentle agitation for 30 min at 37°C. The digested sample was centrifuged 
at 1200 rcf for 5 min, and the SVF portion was plated with serum‐free stem cell‐specific 
media with bFGF; 10 ng/ml; Sigma, St. Louis, MO) and epidermal growth factor (EGF; 
20 ng/ml; Sigma). In these conditions, S‐ASCs, or called also SASCs-3D,  grew as 
floating spheroids in ultralow culture flasks (Corning, NY) and placed at 37° C in a 5% 
CO2 humidified incubator (Di Stefano et al., 2015). The SVF was also resuspended in 
DMEM complemented with 10% FBS for growth under standard adherent (AD.) 
conditions ASCs-2D. Cell media was replaced twice a week.  ASCs were the 
commercially available STEMPRO® human adipose‐derived stem cells, plated as 
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recommended by the manufacturer (Invitrogen, Carlsbad, CA).  
2.3 MicroRNA Profiling  
miRNAs were extracted from cultured cells using the miRNeasy® Mini Kit (Qiagen, 
Germantown, MA) and quantified using a NanoDrop spectrophotometer. Reverse 
transcription (RT) was performed using a TaqMan® microRNA Reverse Transcription 
Kit (Applied Biosystems, Carlsbad, CA) and Megaplex RT primers (Human Pool A; 
Applied Biosystems) following the manufacturer’s instructions. RT was performed on 
a 9700 thermocycler (Applied Biosystem) with the following cycling conditions: 40 
cycles at 16°C for 2min, 42°C for 1min, and 50°C for 1 s, followed by a final step of 
85°C for 5 min to inactivate reverse transcriptase. MegaplexTM RT products were 
mixed with RNase‐free water and TaqMan® Universal PCR Master Mix, No 
AmpErase® UNG, 2× (Applied Biosystem) and then loaded into TaqMan Human 
MicroRNA Array A (Applied Biosystems). Realtime polymerase chain reaction (PCR) 
based microfluidic card with embedded TaqMan primers and probes in each well for 
the 380 different mature human miRNAs and controls was performed on an ABI 
PRISM 7900HT system (Applied Biosystems) using the 384‐well TLDA default 
thermal‐cycling conditions: 50°C for 2 min, 94.5°C for 10 min, and 97°C for 30 s, 
followed by 40 cycles at 95°C for 30 s and 59.7°C for 1 min. The cycle threshold was 
automatically calculated using SDS 2.4 software (Applied Biosystems) and miR‐191 
was used as an endogenous control. Human MicroRNA Arrays were all performed in 
triplicate on three different samples. The relative expression levels of miRNAs were 
calculated using the comparative ΔΔCt method, and fold changes in miRNAs were 
calculated by the equation 2−ΔΔCt . 
2.4 Single miRNA assay 
RT was performed for each miRNA using the TaqMan MicroRNA Reverse 
Transcription Kit (Applied Biosystems). A total of 15 μl reaction was incubated for 30 
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min at 16°C, 30 min at 42°C, and 5 min at 85°C. Real‐time PCR was performed on ABI 
Prism 7900HT System (Applied Biosystems) at 95°C for 10 min, followed by 40 cycles 
at 95°C for 15 s, and 60°C for 1 min. The quantitative reverse‐transcriptase PCR 
reactions were all performed in triplicate on three different samples. The predesigned 
Taqman primers (Thermo Fisher) were: MIR142-3P 000464, MIR221 000524, MIR100 
002142, MIR495  001663, MIR140 001187, MIR30C 000419 , MIR143 002249.The 
cycle threshold was automatically calculated using SDS 2.4 software (Applied 
Biosystems) and miR‐191 002299 . was used as an endogenous control. The relative 
expression levels of individual miRNAs were calculated using the comparative ΔΔCt 
method, and the fold changes in miRNAs were calculated by the equation 2−ΔΔCt . 
2.5 mRNA expression profile 
Total mRNAs were extracted from cells using an RNeasy Mini Kit (Qiagen) and 
quantified using a NanoDrop spectrophotometer. RT was performed using the High 
Capacity cDNA Reverse Transcription kit (Applied Biosystems) in 350 ng of RNA. A 
total of 50 μl reaction was incubated for 10 min at 25°C, 120 min at 37°C, and 5 min at 
85°C. RT‐PCR was performed on ABI Prism 7900HT System (Applied Biosystems) at 
50°C for 2 min and 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and 60°C 
for 1 min. The RT‐PCR reactions were all performed in triplicate on three different 
samples. The predesigned Taqman primers (Thermo Fisher) were: SOX2 
Hs01053049_s1; POU5F1 Hs00999632_g1; NANOG Hs04399610_g1; RUNX2 
Hs01047975_m1; ALPL Hs01029144m1,SOX9 Hs00165814_m1; COL10A 
Hs00166657_m1 ;PPARG  Hs01115513_m1; LPL Hs00173425_m1; SIRT1 
Hs01009006_m1; CDKN2A Hs00923894_m1; TINF2 Hs00173291_m1; TERF2 
Hs00194619_m1; TERF2IP Hs00430292_m1; TERT Hs00972650_m1, GAPDH 
Hs02758991_g1; TGF-β1 Hs00998133_m1. Primer sequences of to detect ALDHs 
isoforms were as follows: hALDH1A1 fw-: TTGGAAATCCTCTGACCCCA,rv 
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CCTTCTTTCTTCCCACTCTC; hALDH1A2 fw- CATTGGAGTGTGTGGACAGA, 
rv- GGAGCTATTTTCCAGGCA; hALDH1A3 fw- TTTTCATCGACCTGGAGG, rv- 
GACGTTGTCATCTGTGGG; hALDH1B1 fw-ACTTGGCCTCACTCGAGA, rv- 
CCAGCAAAGTACCGATAC; hALDH3A1 fw- CACATCACCTTGCACTCTCT, rv- 
AGCTCTTCTTGCCATGGT; hALDH3A2 fw-TAGCTTTTGGTGGGGAGA, rv- 
CTTGCATCACCTTGGTTT; hALDH3B1 fw-TATCTAATCACGGGCCA, rv- 
AGCTGCTTGTTTTCTTGC; hALDH3B2 fw TTCTCCAACAGCAGCCAG, rv- 
CGGACAGCAGAGATATGTAG. 
The cycle-threshold was automatically calculated using SDS 2.4 software (Applied 
Biosystems), and glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) was used as 
an endogenous control. The relative expression levels of mRNAs were calculated using 
the Livak method by the equation 2−ΔΔCt. 
2.6 Digital PCR 
The QuantStudio™ 3D Digital PCR (dPCR) platform (Thermo Fisher Scientific) was 
used to confirm the miRNA expression pattern obtained with real‐time PCR. The 
analyses were conducted in triplicate using miRNAs isolated from both S‐ASCs and 
ASCs (n = 3). The dPCR was performed in a final volume of 15 μl as follows: 2.25 μl 
of complementary DNA (concentration 2 ng), 8 μl of QuantStudio™ 3D dPCR Master 
Mix (Thermo Fisher Scientific, Carlsbad, CA), 4 μl of nuclease‐free water, and 0.75 μl 
of TaqMan MicroRNA Assay (Thermo Fisher Scientific) for miR‐142‐3p. The sample 
mix was loaded on a chip using the QuantStudio 3D Digital PCR Chip loader (Thermo 
Fisher Scientific), and then PCR reaction was performed on ProFlex™ 2× Flat PCR 
System (Thermo Fisher Scientific) with the following cycling conditions: 96°C for 10 
min, 40 cycles (2 min at 56°C and 30 s at 98°C) and a final hold at 60°C for 2 min. 
After PCR amplification steps, QuantStudio™ 3D Digital PCR chips were first read 
through QuantStudio™ 3D Instrument and then analyzed through QuantStudio™ 3D 
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Analysis Suite Software (Thermo Fisher Scientific).  
2.7 Cell viability 
Cell viability was quantified with CellTiter 96 Aqueous One Solution Cell Proliferation 
Assay (Promega); 50.000 cells/well were plated in biological and replicative triplicate. 
The absorbance at 490nm was analysed at 24h, 14 and 28 days of culture condition, 
respectively, in ultralow 96-well plate for SASCs-3D and in adherent 96-well plate for 
SASCs-3D AD and ASCs-2D. Detection of cell death was performed using FITC 
Annexin V Apoptosis Detection Kit I (BD Biosciences).  Cells were collected and 
washed twice in PBS, resuspended in 1X Binding Buffer and stained with 5µl of 
fluorescein isothiocyanate (FITC)-conjugated Annexin V for 20 minutes at room 
temperature in the dark. Then they were washed once with PBS and stained with 7-
aminoactinomycin D (7-AAD) Viability Staining Solution (eBioscience) for 5 minutes. 
All samples were analysed by FACS ARIA flow cytometer (BD Bioscience, USA) and 
also analysed using FlowJo software (Tree Star, version 10.5.3). 
2.8 Cytochemical and Immunofluorescence staining 
The cytoblocks, which were 4‐μm‐thick sections, were cut, deparaffinized, rehydrated, 
and evaluated with hematoxylin and eosin staining. Sections were analyzed under the 
Axio Scope A1 optical microscope (Zeiss, Jena, Germany), and microphotographs were 
collected using the Axiocam 503 Color digital camera (Zeiss). 
For immunofluorescence staining, the sections were were incubated with primary 
antibodies: rabbit polyclonal anti‐human SOX2 (SP76, catalog number 760‐4621; 
Ventana, Roche, CA), rabbit polyclonal anti‐human NANOG (N3C3, catalog number 
GTX100863; Genetex, Irvine, CA), and rabbit polyclonal anti‐human Oct‐4A (C30A3, 
catalog number 2840; Cell Signaling Technology, Danvers, MA). After Fc blocking, 
primary antibodies binding was revealed by fluorochrome‐conjugated secondary 
antibodies: Alexa Fluor 488‐conjugated goat anti‐rabbit IgG (H+L, A11008 Lot 
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1583138; Invitrogen Molecular Probes, Carlsbad, CA). The slides were counterstained 
with DAPI nucleic acid stain (Invitrogen Molecular Probes). Confocal analysis was 
used to acquire fluorescence staining. 
2.9 Mesenchymal differentiations 
Mesenchymal differentiation was performed with a specific cell medium to induce 
chondrogenic, adipogenic, and osteogenic differentiation by means of the STEMPRO® 
Differentiation Kit (Invitrogen), and S‐ASCs were cultured in adhesion conditions until 
28 days. Cell viability, adhesion, and differentiation were assessed by daily observation 
using optical microscopy. 
2.10 Telomere length analysis 
Chromosomal DNA from the samples was extracted using the QIAGEN DNeasy kit for 
blood and tissues according to the manufacturer's protocol. After quantification with 
NanoDrop 2000, DNA (35ng/reaction) was analysed according to Cawthon method 
(Cawthon, 2002). Telomere (T) gene and single copy gene (S) were quantified with 
different SYBRgreen RT-PCR condition (18cycles for T and 30cycles for S) in separate 
96-well plates. The primer sequences were: tel 1, 
GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGT (270 nM); tel2   
TCCCGACTATCCCTATCCCTATCCCTATCCCTATCCCTA (900 nM); 36B4u 
CAGCAAGTGGGAAGGTGTAATCC (300 nM); 36B4d 
CCCATTCTATCATCAACGGGTACAA (500 nM). The reaction volume was 20 
μl/well. T/S ratio, that is the relative expression level of the target/single copy gene in 
DNA samples, was calculate using Livak method (2−ΔΔCT)(Livak and Schmittgen, 
2001). 
2.11 mRNA array of human telomere complex genes 
The human telomere complex genes expression profile was analysed using the TaqMan 
Array 96-well Plate Human Telomere Extend by Telomerase (Thermo Fisher 
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Scientific), a comprehensive collection of predesigned, pre-formulated primer and 
probe sets to perform quantitative gene expression in 96‑well plate standard. Of 28 
genes in triplicate, 19 are Telosome-associated genes and 9 are endogenous controls, 
which were analysed by quantitative real-time PCR (qPCR). Total mRNAs were 
extracted from cells using RNeasy Mini Kit (Qiagen) and quantified using a 
spectrophotometer NanoDrop 2000. 450ng of total mRNA were retro-transcribed in 
cDNA using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems). 
The qPCR reactions were performed on an ABI PRISM 7900HT system (Applied 
Biosystems), in triplicate on three different samples SASCs 3D and ASCs 2D using 20µ 
l of cDNA in 96-well Plate with embedded TaqMan primers and probes for 28 human 
gene.  Reaction mixtures for amplification and thermal condition were set according to 
the manufacturer's protocol. Relative expression was normalised to the mean of the 
reference beta-2-microglobulin (B2M) gene, using the Livak’s method. 
2.12 Lipid peroxidation and ROS assay  
Lipid peroxidation was measured using the Lipid Peroxidation Sensor BODIPY™ 
581/591 C11, following manufacturer’s instructions (Life technologies). Briefly, 2x10⁵ 
SASC-3D and ASC-2D cells were incubated with 10µM BODIPY in a 1 ml volume of 
PBS for 30 minutes at 37°C and analysed using a FACS ARIA flow cytometer (BD 
Bioscience, USA). Cellular ROS production was measured using the total Reactive 
Oxygen Species (ROS) Assay kit (Invitrogen).  3x10⁵ cells from 2D and 3D cultures 
were treated with 1X ROS fluorescence probe in a 1mL volume of PBS for 60 minutes 
and incubated at 37°C in a humidified atmosphere containing 5% CO₂. ROS levels were 
assessed by flow cytometry. 
2.13  Cytokine analysis 
To study intracellular IL-10 and TGF-β expression, cells were harvested, washed twice 
in PBS cointaning 1% FCS and fixed with Inside Fix (Inside Stain Kit, Miltenyi Biotec, 
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Auburn, CA, USA), containing 3.7% formaldehyde for 30 minutes at room temperature 
protected from light. Fixation was followed by permeabilization with Inside Perm 
(Inside Stain Kit, Miltenyi Biotec, Auburn, CA, USA), containing a detergent and 
0.05% sodium azide. Staining of intracellular cytokines was performed by incubation 
of permeabilized cells with PE‐labelled anti‐IL-10 (clone JES3-9D7, Miltenyi Biotec, 
Auburn, CA, USA) and APC‐labelled anti-TGF-β1 (clone CH6-17E5.1, Miltenyi 
Biotec, Auburn, CA, USA) for 20 minutes at room temperature in the dark.  Following 
two additional washes in PBS containing 1% FCS, cells were analyzed by FACS ARIA 
flow cytometer (BD Bioscience, USA). Viable cells were gated using forward and side 
scatter criteria and the analysis were performed on 100.000 acquired events for each 
sample by using FlowJo software (Tree Star, version 10.5.3). 
2.14  Statistical analysis 
Data are expressed as mean ± standard deviation of three independent experiments. 
Statistical significance was calculated using one-way analysis of variance (ANOVA), 
followed by either a Tukey’s or Bonferroni’s multiple comparison post hoc test. 
Significance levels were analysed with GraphPad Prism 5 statistical software and 









3.1 miRNA array profiling 
To obtain new insights on the stemness potential of S‐ASCs, we investigated their 
miRNA expression profile. In particular, a screening analysis and relative quantification 
of 377 modulated miRNAs were performed through real‐time PCR, comparing S‐ASCs 
with their adherent counterpart ASCs (Figure 2A). miRNAs were analyzed using 
TaqMan MicroRNA Assays (Panel A Cards; Thermo Fisher Scientific), and miR‐191 
was used as endogenous control. In the S‐ASC population, we reported 26 upregulated 
miRNAs (14%) and 56 downregulated miRNAs (25%); 46% miRNAs were 
undetermined as Ct values were higher than 35, whereas no differences were reported 
for 15% miRNAs (Figure 2B). Differentially expressed miRNAs with statistical 
significance were identified by volcano plot analysis (Figure 2C). A fold change greater 
than two was used as cutoff to identify significantly deregulated miRNAs (Figure 
2D,E). The analyses were conducted in triplicate on three different biological replicates, 
and miRNA expression levels were calculated as a mean between the triplicates. Based 
on further and more detailed literature reviews, we decided to proceed our investigation 
by focusing on those miRNAs reported to be specifically involved in stemness and 




3.2 S‐ASCs express a high level of miR‐142‐3p and stemness genes typical of 
iPSCs 
Among 26 upregulated miRNAs, miR‐25, and miR‐142‐3p were 16‐ and 20‐fold 
increased, respectively (Figure 2). Interestingly, these two miRNAs are known to be 
involved in the self‐renewal and maintenance of pluripotency in stem cells, in particular 
in iPSCs, in which they have been found to be highly upregulated. Analysis of their 
targets by Lu et al. (2012) showed that both the ubiquitin ligases (RBR‐E3), WW 
domain containing E3 ubiquitin protein ligase 2 (Wwp2) and F‐box and WD repeat 
domain containing 7 (Fbxw7), which target OCT4, are regulated by miR‐25 (Lu et al., 
2012). Similarly, miR‐142‐3p is also upregulated in iPSCs and is involved in stemness 
maintenance and proliferation regulation in some mesenchymal lineages (Abdul Razak 
et al., 2014). Our analysis showed that miR‐142‐3p is surprisingly upregulated in the S‐
ASC population (20‐fold) compared to the ASCs (Figure 3B). These data were also 
confirmed with digital PCR, allowing the absolute quantification of miR‐142‐3p with 
greater sensitivity (Figure 3C). We proceeded to investigate the expression levels of 
three typical genes involved in stemness, self‐renewals, and plasticity: SOX2, NANOG, 
and OCT4 (Loh et al., 2006), (Riekstina et al., 2009). The analysis was performed using 
real‐time PCR and demonstrated that the S‐ASCs expression levels of SOX2, NANOG, 
and OCT4 were more than two‐fold greater compared with those found in ASCs (Figure 
3B). Moreover, we decided to analyze through immunostaining the protein expressions 
of SOX2, NANOG, and OCT4 in paraffin‐embedded S‐ASCs, confirming also the 
expressions of these mRNAs at the protein level (Figure 3D). These important findings 
support our thesis, according to which S‐ASCs have superior stemness features 




3.3 S‐ASCs express a low level of miRNAs and mRNAs related to early and late 
chondrogenic differentiation  
Nowadays, it is well known that the miRNA and mRNA expression levels are subjected 
to change during the progression from stem cells to differentiated cells (Chen et al., 2014). 
Accordingly, mRNA and miRNA expression profiles may change along mesenchymal 
differentiation (Kuosmanen et al., 2017) , and therefore we decided to investigate the most 
representative miRNAs involved in early and late chondrogenic differentiation stages in 
3D S‐ASCs. In particular, elevated levels of miR‐495 have been reported in the early 
chondrogenic differentiation stage (Lee et al., 2014), whereas the upregulation of miR‐140 
is associated with the late stage of differentiation (Karlsen et al., 2014). Therefore, we 
cultured both S‐ASCs and ASCs under chondrogenic condition, and we evaluated the 
expression levels of miR‐495 and miR‐140 (Figure 4A). We showed that S‐ASCs express 
a lower level of miR‐495 compared with ASCs, suggesting that the adherent counterpart 
could probably be considered as precursors or progenitors rather than as real stem cells. 
To confirm the involvement of miR‐495 in early stage differentiation, we analysed this 
miRNA in S‐ASC‐derived chondrocytes, obtained after 28 days of culture. As expected 
and in accordance with our thesis, S‐ASC‐derived chondrocytes express low levels of miR‐
495, demonstrating that this miRNA is lost in the late differentiation stage. We also 
analyzed a direct target of miR‐495, the SOX9 gene (SRY‐box 9), which is known to be 
involved in chondrogenesis since the earlier stages. As expected, SOX9 mRNA levels 
appear to be inversely correlated to miR‐495. Indeed, SOX9 is downregulated in S‐ASCs, 
whereas it is increased in chondrocytes after 28 days of in vitro differentiation (Figure 4A). 
On the contrary, the levels of miR‐140, which is involved in the late chondrogenic 
differentiation stage, are higher in ASCs and chondrocytes after 28 days of culture 
compared with both S‐ASCs. Mature chondrocytes express high levels of miR‐140 as they 
enter in a state of hypertrophy during chondrogenic differentiation. We also evaluated the 
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expression of collagen type X α1 chain gene COL10A1 gene, an important late 
chondrogenic differentiation marker. As expected, no expression of COL10A1 was 
reported in both S‐ASCs and ASCs, whereas higher expression levels were reported in 
differentiated chondrocytes. For all the experiments here reported, we used miR‐191 and 
GAPDH as endogenous control for miRNA and mRNA analyses, respectively (Figure 4A). 
 
3.4 S‐ASCs express a low level of miRNAs and mRNAs related to early and late 
adipogenic differentiation 
As previously studied in chondrogenic differentiative lineage, we also aimed to study 
the molecular changes that characterize the adipogenic differentiation process. From 
the literature, we know that miR‐30c promotes adipocyte differentiation and could be 
considered as representative of early adipogenic stages (Karbiener et al., 2011). 
Therefore, we investigated the level of miR‐30c in SASCs, ASCs, and S‐ASC‐derived 
adipocytes obtained after 28 days of culture under adipogenic condition. In particular, 
S‐ASCs showed a downregulation of miR‐30c compared to adherent ASCs, whereas 
adipocytes showed the highest level of miR‐30c. We then evaluated the mRNA level of 
peroxisome proliferator activated receptor γ (PPARG), which is normally expressed 
since the earlier phases of adipogenic differentiation and is a target of miR‐30c. 
Unexpectedly, we found a higher expression of PPARG in S‐ASCs than in adherent 
ASCs; this interesting result gives us reason to speculate that S‐ASCs are heterogeneous 
primary cell lines with probably still residual mature adipose cells with respect to ASCs 
that are pure, homogenous, commercially available cells. Considering the late 
adipogenic differentiation marker, we chose to investigate miR‐143 (An et al., 2016) 
and lipoprotein lipase (LPL) mRNA. We showed that miR‐143 expression strongly 
increases during the differentiation from S‐ASCs to adipocytes after 28 days of culture. 
Furthermore, according to the literature (Preiss-Landl et al., 2002), LPL mRNA is 
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absent in S‐ASCs and ASCs, whereas it is highly expressed in differentiated adipocytes. 
The aforementioned results increasingly support the idea of the strong stemness 
properties of S‐ASCs (Figure 4B). 
 
3.5 S‐ASCs express a low level of miRNAs and mRNAs related to early and late 
osteoblastic differentiation 
In this analysis, we focused mainly on osteogenic differentiation because Di Stefano et 
al 2015 have previously demonstrated the enhanced osteoinductive properties of S‐
ASCs in a small‐animal vertebral lesion model (Di Stefano AB 2015). Indeed, we 
showed that S‐ASCs grown on Integra and implanted in a laminectomy site are able to 
actively participate in bone tissue regeneration. With the current study, we wanted to 
make a step forward in understanding the molecular mechanisms underlying this 
important process. For this reason, we decided to study miRNA‐level changes in 
osteoblastic cells at several time points, from 7 to 28 days of in vitro differentiation. In 
particular, according to previous published data (Hoseinzadeh et al., 2016), we analyzed 
miR‐221 that is considered a modulator of earlier osteogenic differentiation stages. 
MiR‐221 seems to be overexpressed in ASCs compared to S‐ASCs, as well as in all the 
differentiated osteoblastic populations obtained from S‐ASCs after 7,14, 21, 28 days of 
culture under osteogenic condition. Moreover, the expression level of runt related 
transcription factor 2 gene (RUNX2), involved since the earlier phase of osteogenesis, 
increases during differentiation, reaching a peak after 21 days of culture. The last 
analysed microRNA is miR‐100, which is related to the late stage of osteoblastic 
differentiation (Zeng et al., 2012). Indeed, miR‐100 is less expressed in S‐ASCs 
compared with ASCs with an increasing trend during osteoblastic differentiation. 
Moreover, the expression of alkaline phosphatase (ALP) mRNA is almost absent in 
both S‐ASCs and ASCs, whereas it increases during osteoblastic differentiation (Figure 
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4C). All these data confirm once again the highly undifferentiated stage of our cell line 
compared to adherent ASCs. 
 
3.6 Molecular analysis during long‐term in vitro culture in S‐ASCs and ASCs  
We have also investigated whether the expression profiles of both miRNA and mRNA 
undergo changes during long-term in vitro culture at different time points (1, 14, and 
28 days) in S‐ASC and ASC models. We showed that miR‐142‐3p remains stably 
expressed at high levels in the S‐ASC population until 28 days (Figure 5A); 
accordingly, SOX2, NANOG, and OCT4 expressions are greater in S‐ASCs compared 
with those in ASCs (Figure 6A, B, C). The analysis of the previously discussed early 
and late differentiation miRNAs showed a similar trend also during long‐term culture 
in S‐ASCs and ASCs (Figure 5B, C, D). These interesting data further demonstrate the 
ability of S‐ASCs to keep their stem properties analyzed so far up to 28 days. Overall, 
we observed an increasing trend of miRNA expression in S‐ASCs along the different 
time points in long‐term cultures. However, this miRNA expression behavior still 
remains definitely lower than ASCs. Moreover, miR‐30c, PPARG, and LPL showed an 
expected permanently upregulated behavior. This result may be due to the 
heterogeneous nature of the S-ASCs population, and therefore there might be an adipose 
memory. In ASCs, early miRNA expression levels were maintained or instead 
progressively increased, whereas tardive miRNAs decreased during long‐term culture. 
Chondrocyte (except for COL10A1) and osteoblastic mRNAs maintained the same 
miRNA trend in both S‐ASCs and ASCs. This could be explained considering the 
possibility that S‐ASCs progress from stem cell to precursor-progenitor cells, whereas 
ASCs can be considered more as progenitors than pure stem cells that undertake the 




3.7 Morphology and viability of 2D versus 3D cell culture conditions  
Cell cultures of SASCs-3D, established in ultra-low attachment surfaces (U.L.) and 
which cells are majorly in a quiescent state exhibited a slight decline in MTS enzymatic 
reduction at 28 days of culture compared to the ASC-2D, which in contrast are known 
to be in active proliferation due to serum stimulation and adhesion condition (Figure 
7A and B). To dissect the sole contribution of plate surfaces to these differences, we 
plated SASCs-3D in flasks treated to promote cell adhesion (AD.) while maintaining 
the same stem cell medium and evaluated eventual changes in the growth and spatial 
distribution of cells. The enhanced attachment condition did not modify SASCs 
viability and overall, their round shape was preserved; however, the original 3D 
organization was maintained no longer than 20 days of culturing (Figure 7A). Beyond 
20 days, spheroids started to adhere to the flask surface an acquired the typical 
fibroblastoid shape that is characteristic of ASCs in adhesion. The MTS assay revealed 
no significant difference in the metabolic activity of SASCs-3D AD. at 1, 14 and 28 
days of cultures (Figure 7B). To assess apoptosis, Annexin V/7-AAD staining was use. 
We found no significant differences between the 3D and 2D culture conditions during 
the first 14 days (14-21% of early apoptotic events). At 28 days, these events diminished 
in SASCs-3D (9%) compared to adherent cells (28-30% of total) (Figure 7C). These 
differences could be inherently related to primary cultures and their lengthy adaptation 




3.8 Comparative evaluation of stemness and aging related genes 
Expression profiles analysis of the stemness-related genes SOX2, POU5F1 and 
NANOG, in SASCs-3D and ASCs-2D at 14 and 28 days of culture, revealed an increase 
of at least 1.5-fold in the expression of all genes in SASCs-3D compared to ASCs-2D. 
Consistent with the expression of SOX2 protein in SASCs-3D, the transcript levels of 
the gene were 2.5-fold and 1.7-fold higher in SASCs-3D compared to ASCs-2D at day 
14 and 28 days, respectively, (P < 0.001) (Figure 8A,B). In vitro, cellular aging is 
affected by culture-related conditions, especially serum exposure (Søndergaard et al., 
2017). Lifespan of mesenchymal stem cells (MSCs) is limited and as in vitro culturing 
is prolonged their differentiation potential diminishes and cells progress to replicative 
senescence (Wagner et al., 2009). On this basis, we analysed the expression level of the 
anti-aging marker Sirtuin1, and we found higher expression of this gene in SASCs-3D 
compared to ASCs-2D ones (14d: P< 0,001 and 28d: P< 0.01),found opposite 
expression pattern for the senescence and apoptotic marker CDKN2A, also called 
p16INK4a, which was significantly down-regulated in SASCs-3D compared to ASCs-
2D (4-fold) (P < 0.001) (Figure 8 C,D). 
 
3.9 Comparative evaluation of telomeric length and telomere-associated genes 
To further investigate the aging-related changes between SASCs-3D and ASCs-2D, we 
performed a comparative analysis of telomeric length, using the qPCR method 
described by Cawthon (Cawthon, 2002). This test showed that the T/S ratio was similar 
in SASCs-3D and ASCs-2D, with a fold change of approximately 1 at both time points 
(Fig. 9A/B). Surprisingly, in both culturing conditions we observed an increase (3-fold) 
of the T/S ratio at 28 days compared to 14 days. We also quantified 19 genes associated 
to human telomeres using a Human Array Telomerase card (Invitrogen) that included 
genes of the Shelterin complex and co-factors (Fig. 9C), RNA binding protein (Fig. 9E) 
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and DNA repair genes (Fig. 9F) 28 days. We found an increase of TINF2 (~1.5 fold), 
TERF2 (~3 fold), HNRNP-A1 (~2 fold), HNRNP-F (~2 fold), RAD50 (~3 fold) and 
XRCC5 (~2 fold) expression levels in SASCs-3D compared to ASCs-2D, while all the 
others genes, except tankyrase 2 (TNKS2), HNRNP-C and NBN were significantly 
downregulated. We validated these expression differences for TINF2, TERF2 and 
TERF2IP members of the Shelterin complex (Fig. 9D). Intringuigly, the expression of 
HTERT was low or undetected in SASCs-3D and ASCs-2D using both assays, the card 
and qPCR. This is consistent with a previous report describing undetected HTERT in 
adipose stem cells (Zimmermann et al., 2003); (Samsonraj et al., 2013); (Trivanović et 
al., 2015). 
 
3.10 Comparative evaluation of oxidative environment and redox homeostasis 
Two functional tests were performed to evaluate the oxidative state of cells in 3D vs 2D 
conditions. These tests revealed that SASCs-3D have lower endogenous levels of ROS 
(~2.7 -fold at 14d and 4-fold at 28d) and in general lower values of lipid peroxidation 
than ASCs-2D (Fig. 10 A and B). An increasing number of studies have identified 
ALDHs as an important marker of normal and cancer stem cells (Najar et al., 2018); 
(Vassalli, 2019). ALDHs are known to participate in cell differentiation in which ALDH 
class 1 plays a central role in modulating the retinoic acid levels dynamically (Vasiliou 
et al., 2000). Other members of the ALDH family, such as ALDH class 3 enzymes are 
known to mitigate cellular oxidative stress via oxidation of HNE and MDA formed as 
secondary products during lipid peroxidation (Black et al., 2012). Consistent with the 
lower levels of lipid peroxidation exhibited by SASCs-3D, we found that three members 
of ALDH-3 family (ALDH3A1, ALDH3A2 and ALDH3B2) were up-regulated in 
SASCs-3D compared to ASC-2D (Figure 10C). Interesting, ALDH1 family members 
ALDH1A1, ALDH1A3 and ALDH1B1 were significantly down-regulated in SASCs-
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3D (Figure 10D). 
 
3.11 Comparative evaluation of cytokine production 
The production and secretion of cytokines has been reported as an essential function of 
ASCs (Razmkhah et al., 2011). We analysed the expression of TGF-β1, an important 
anti-inflammatory cytokine, at both transcript and protein level. We found the cytokine 
mRNA levels consistently increased (3-fold) in SASCs-3D all along the period of 
culturing (Figure 11A/B). Importantly, the percentage of cells positive for TGF-β1was 
also increased in SASCs-3D compared to ASCs-2D (60% and 80% SASCs-3D vs 36% 









Two‐dimensional cell cultures are a very useful tool to perform in vitro studies in the 
fields of oncology, stem cell biology, and tissue engineering. Nevertheless, it has been 
recently questioned whether the 2D model properly represents the original tissue. 
Indeed, whereas cells cultured in monolayer lose their tissue specificity, 3D cultures 
exhibit protein expression patterns and intercellular junctions that are similar to in vivo 
condition. Stem cell therapy success is largely determined by the “cell quality” of the 
implanted cells (Lindroos et al., 2011). Preserving stem-like features are fundamental 
for successful treatment. A 3D environment stimulates cells to grow in suspended 
aggregates that are defined as “spheroids.” We have previously demonstrated that S‐
ASCs can be directly obtained from lipo-aspirated samples, using the SVF portion 
cultured in serum‐free and low‐adhesion conditions. Moreover, our S‐ASCs showed 
important regenerative potential, demonstrated by their capacity to actively participate 
in bone tissue regeneration in a small animal model (Di Stefano AB 2015). We wanted 
to further characterize SASCs 3D to make a step forward in understanding the 
molecular mechanisms underlying their stemness properties. We demonstrate that 
SASCs 3D represent a distinct upstream state from the currently studied ASCs 
expanded in 2D adherent monolayer cultures. Adherent stem cells have started their 
initial differentiation by expressing adhesion molecules and therefore should be termed 
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more generically as mesenchymal stromal cells. In contrast, SASCs 3D are a unique 
cell population that has not undergone differentiation induced by culture conditions, 
which their adherent counterparts are subject to (Leto Barone et al., 2013). Indeed, we 
provide evidence that the 3D environment in which SASCs-3D are cultured seems to 
increase their capacity to maintain a pluripotent behaviour after multiple passages as 
compared to MSCs. These important findings provide a robust basis to further 
investigate the application of SASCs-3D in regenerative medicine. 
 We identify a number of “cell quality” factors through the evaluation of genes 
expression involved in stemness, miRNA expression profiles, oxidative stress, aging, 
and telomere length and maintenance on spheroids from adipose derived stem cells 
(SASCs) when adipose stem cells are culture in 3D vs 2D conditions. The different 
behaviour of SASCs-3D and ASCs-2D suggests specific intrinsic properties determined 
by culturing conditions. About miRNAs profile, after an initial analysis of 380 
miRNAs, we focused on miR‐142‐3p for different reasons. Although miR‐142 was first 
identified in hematopoietic cells (Skårn et al., 2013), there is evidence of its expression 
also in other cells, such as induced iPSCs, MSCs, colon cancer cells (Shen et al., 2013), 
and hepatocellular carcinoma cells (Wu et al., 2011). miR‐142‐3p expression is 
modulated by DNA methylation of CpG islands located in the enhancer region. DNA 
methylation determines a transcription repression and indeed in undifferentiated iPSCs 
CpG motifs of miR‐142‐3p enhancer region are not methylated; contrariwise, the same 
region is methylated in fibroblasts determining the complete absence of miR‐142‐3p in 
these cells. Using the Genomatix Software Suite, (Abdul Razak et al., 2014) have 
identified putative binding sites for MYC protooncogene, bHLH transcription factor 
(MYC), and SOX2 in the genomic region up to 1 kb from the miR‐142 mature sequence. 
Therefore, these transcription factors are involved and cooperate in the full induction of 
miR‐142‐3p expression. Furthermore, the physiology of iPSCs can be probably 
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regulated by transforming growth factor β1 and WNT family member 1 (WNT1) 
pathways (Abdul Razak et al., 2014). Canonical WNT1 signaling participates also in 
bone formation, and it was demonstrated that miR‐142‐3p  expression is correlated with 
osteoblastic differentiation, by repressing adenomatous polyposis coli expression (Hu 
et al., 2013). We showed, for the first time, miR‐142‐3p is highly expressed in SASCs-
3D compared to ASCs-2D, suggesting that these cells possess similar molecular 
characteristics to iPSCs. Moreover, and to confirm our hypothesis, we observed an 
overexpression of three of Yamanaka’s factors, such as NANOG, OCT‐4, and SOX2 in 
3D S-ASCs. These results demonstrate a real difference between two adipose stem cell 
populations, in suspension and in adhesion, suggesting that probably SASCs maintained 
an upstream evolutive stage compared to their adherent counterpart. We report further 
data that endorse this hypothesis since we have also conducted a detailed molecular 
analysis of miRNAs and mRNAs involved in typical mesenchymal differentiation 
lineages. We investigate some miRNAs involved in two distinct moments of 
differentiation, namely, early and late stages of chondrogenic, adipogenic, and 
osteogenic lineages. The analysis highlighted the downregulation of early stage markers 
(miR‐495, miR‐30‐c, and miR‐221) in S‐ASCs compared to ASCs. The late stage 
miRNAs (miR‐140, miR‐143, and miR‐100) were almost absent in S‐ASCs, whereas in 
ASCs they were already detectable and they strongly increase in mature differentiated 
cells (chondrocytes, adipocytes, and osteoblasts) in both cell lines. A similar trend was 
observed among the mRNAs involved in early and late stages, in particular the early 
markers were downregulated in S‐ASCs, except for PPARG (as explained above) and 
the late are equally absent in both populations. Furthermore, during in vitro passages, 
we showed that the stemness markers, miR‐142‐3p and SOX2/NANOG/OCT4, were 
maintained until 28d in S‐ASCs, demonstrating the maintenance of the stemness 
characteristics during long‐term cultures (Di Stefano et al., 2018). In 3D cultures, the 
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secretory activity is greater and cytokines and growth factors reach higher 
concentrations favouring effective cell communication. More so, each cell has a greater 
number of contacts with adjacent cells and the extracellular matrix acts as a mesh, 
scaffold and modulator of cell growth, proliferation, and differentiation  (Lee et al., 
2018). In vivo, MSC spheroids have been shown to secrete more anti-inflammatory and 
proangiogenic factors to improve tissue repair  (McMillen and Holley, 2015). This is in 
good agreement with the increased production of important anti-inflammatory factors 
such as TGF-β1 in SASCs-3D culture compared to ASCs-2D as revealed in this thesis 
and in associated work (Di Stefano et al., 2020a) .Intriguingly, we were unable to detect 
SASCs-3D or ASCs-2D that produced IL-10 cytokine. This cytokine is well described 
as to be mainly secreted by immune-regulatory cells but whether this also pertains to 
adipocytes remains unclear. In a very recent study, Juan R Acosta et al. concludes that 
macrophages are the predominant source of IL-10 in human white adipose tissues and 
that this cytokine does not directly affect human adipocyte function (Acosta et al., 
2019). In the absence of SIRT1, MSCs prematurely lose their capacity for self-renewal 
and show an up-regulation of cell cycle inhibitors, anticipating replicative senescence 
(Yoon et al., 2014). Yoon et al demonstrated that SIRT1 deacetylase positively regulate 
the SOX2 expression in the bone marrow-MSCs (BM-MSCs), which is consequently 
overexpressed (Yoon et al., 2014). These experiments concur with our findings of 
SOX2 and SIRT1 expression changing in the same direction. Consistent with SOX2 
and SIRT1 association to self-renewal, we found both genes significantly up-regulated 
in SASCs-3D compared to ASCs-2D cultures. Also interesting, the expression of 
CDKN2A, a gene involved in the regulation of the cell cycle, was significantly down-
regulated (4-fold) in SASCs-3D compared to ASCs-2D cultures. CDKN2A, also called 
p16INK4a has been previously associated to senescence and apoptosis (Martin et al., 
2014). Notably, the expression of this gene is reported to increase as mesenchymal stem 
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cells age and undergo senescence (Burrow et al., 2017). Telomeres have the important 
function of protecting chromosome ends from degradation by DNA repair mechanisms, 
therefore preventing the formation of chromosomal aberrations. Also, they provide a 
non-coding DNA pad whose purpose is to prevent a progressive shortening of the ends 
that occurs with replication, the so-called fine-replication problem. Telomerase is found 
expressed in highly proliferating cells during embryogenesis, while it is dramatically 
down-regulated as cells undergo differentiation to the point to be undetectable in many 
adult somatic cells. Accordingly, high expression levels of TERT is considered one of 
the landmarks of the pluripotent state (Flores and Blasco, 2010). The analysis on the 
telomeric length showed similar T/S ratio between 3D and 2D experimental culture 
conditions. This match with the fact that SASCs and ASCs comes from adult tissues 
and not from germinal or embryonal stages. Contrary to expectations, we observed a 
slight increase of T/S ratio in primary cultures at 28 days compared to 14 days. Based 
on the absence of TERT, this apparent increase is unlikely to be an elongation of 
telomere length but can be attributed to a negative selection of highly differentiated 
cells and a concomitant enrichment in stem cells or progenitors/ precursors cells, 
favoured by the cell culture condition. Molecules of the Shelterin complex such as 
TERF1, TERF2 and others, and molecules of the non-Shelterin complex such as 
MRE11 complex and the DNA-activated, catalytic subunit (DNA-PK) cooperate 
together to stabilize telomeres. TERF2 and TINF2 genes protect the ends of the 
chromosomes, meaning a down regulation of these genes can lead to a degradation of 
the telomeric extremities and the triggering of cellular senescence. The reduction of 
TERF2 expression can have too a negative impact on the structure of the telomere, 
being TERF2 involved in the formation of the T-loop of the extended DNA strand 
protecting telomeres from the microenvironment (Pirzada et al., 2019). Comparing the 
expression levels of TINF2 and TERF2 in SASCs-3D and ASCs-2D, we found TINF2 
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significantly increased in SASCs-3D at 14 days, while TERF2 mRNA showed 
predominantly higher expression levels at 28 days, thus suggesting that SASCs-3D 
preserved a prolonged proliferation capacity. Interestingly, we also found a significant 
increase of HNRNPA1 (~2-fold), a gene that is suggested to be a positive regulator of 
stem cells renewal and differentiation in smooth muscle (Huang et al., 2013) and 
chondrocyte cells (Meng et al., 2017). In general, little is known about the role of 
HNRNPF in adult stem cells, especially in adipose stem cells. In Embryonal Stem Cells, 
HNRNPF and HNRNPH were previously described to be highly expressed (Yamazaki 
et al., 2018)). SASCs-3D also showed significant increased levels of RAD50 and 
XRCC5, while MRE11 and XRCC6 were downregulated compared to ASCs-2D. 
Mre11-Rad50-NBN (MRN) complex is well known to controls telomere homeostasis. 
It interacts with the ATM complex to detect chromosomal double strand DNA breaks 
(DSBs) and coordinate the overall cellular responses to DNA damage (Stracker and 
Petrini, 2011). All these genes represent DNA protective factors against DNA lesions, 
and participates in the ATM, ATR or NHEJ signalling (de Lange, 2005). The telomere 
end protection is a fine (not a static) controlled process that still remains undefined 
today due to the difficulty in distinguishing the DSBs from dysfunctional telomeric 
ends. It seems that the deletion of a single component minimally impact the repair 
processes activity. Yet, recent studies addressing the complete loss of Shelterin factors 
concluded that telomere uncapping activates at least six different pathways (Mann and 
Markham, 1998); (Sfeir and de Lange, 2012).  mRNAs analysis showed striking 
differences between SASCs-3D and ASCs-2D expression pattern of Shelterin complex 
genes and their associated co-factors, with expression changes occurring in either 
directions.  However, due to the limited information available, the single contribution 
of each gene is difficult to interpret. Further studies in this direction would help us to 
clarify the specific DNA repair pathways that are preferentially activated in SASCs-3D. 
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Another marked observation to emerge from the comparison data is the significantly 
lower endogenous levels of ROS in SASCs-3D compared to ASCs-2D. Accumulating 
evidences points to the beneficial role of ROS in proliferation and cell survival as far 
as its levels are low enough as to not cause concomitant cellular damages (Marengo et 
al., 2016). Indeed, high levels of ROS production lead to apoptosis and is a mechanism 
by which many chemotherapeutic agents can act (Perillo et al., 2020). Beside direct 
actions, ROS also elicit lipid peroxidation, leading to the production of 4-
hydroxynoneal (HNE) and malondialdehyde (MDA) (Gaschler and Stockwell, 2017). 
Not surprisingly, in addition to its higher levels of ROS, ASCs cells also exhibit higher 
lipid peroxidation. HNE and MDA aldehydes issued from lipid peroxidation are highly 
electrophilic and their accumulation in cells lead to formation of adducts with DNA and 
proteins compromising cellular function and eventually  leading to cell death (Kong and 
Kotraiah, 2012). ALDH class 3 subfamily of aldehyde dehydrogenases are capable to 
detoxifies HNE and MDA efficiently by oxidation into their corresponding non-toxic 
and excretable carboxylic acids (Muzio et al., 2012). Significantly, three members of 
ALDH3 subfamily (ALDH3A1, ALDH3A2 and ALDH3B2) are up-regulated in 
SASCs-3D compared to ASCs-2D supporting the idea that SASCs-3D are better 
protected against the deleterious effect of aldehydes generated during lipid-peroxidation 
than ASCs-2D cultures are a similar trend was expected for the ALDH class 1 subfamily 
of aldehyde dehydrogenases, which are widely used as stem cell markers (Tomita et al., 
2016); (Vassalli, 2019). Surprisingly, ALDH1A1 and ALDH1A3 were significantly 
downregulated in SASCs-3D compared to ASCs-2D. However, given that our findings 
are based on adipocytes cells of identic origin, the differences in ALDH1 should be 
interpreted with caution. ALDH1 are the unique members of the ALDH family of 
enzymes that participates in the metabolism of vitamin A and the production of all-trans 
retinoic acid (RA), a small molecule that activate gene transcription through its binding 
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to nuclear retinoic acid receptors (RAR and RXR) (le Maire et al., 2019). As 
consequence, RA acts in several biological conditions, including embryonic 
development and cell differentiation. It can thus be suggested that higher expression of 
ALDH1 in ASCs may result in higher production of RA and consequently a higher 
commitment towards differentiation. This is in good agreement with the use of RA for 
the differentiation of embryonic stem cells into motor neurons or Xenopus ectoderm 
into pancreas (Moriya et al., 2000); (Deshpande et al., 2006). On the basis of our results, 
we propose a model of SASCs “cell quality”, which highlights a precise molecular 
expression profile for several mRNA involved in stemness (SOX2, POU5F1 and 
NANOG), anti-aging (SIRT-1), oxidative stress (ALDH3A1, ALDH3A2 and 
ALDH3B2) and telomere maintenance (TINF2, TERF2, HNRNPA1, HNRNPF, 
RAD50 and XCCR5). All these factors are up-regulated in SASCs compared to the 
traditional adherent ASCs and many others are instead down-regulated. This study 
provides a “transcriptional portrait” of several relevant genes that could assist in the 
evaluation of SASCs fitness; nevertheless, further studies will be required to investigate 
the exact contribution of these genes to the phenotype and functional features of SASCs. 
In our view, these results represent an excellent initial step towards the implementation 
and quality monitoring of long-term adipose stem cell cultures aimed to be used in 
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Full name gene 
 
Functional description 




5460 POU5F1 POU class 5 homeobox 1 Embryonic 
development, stem cell 
pluripotency 
79923 NANOG Nanog homeobox Cell proliferation, 
renewal, pluripotency 
860 RUNX2 RUNX family transcription factor 2 Regulatory factors 
























PPARG peroxisome proliferator activated 
receptor gamma 









2597 GAPDH glyceraldehyde-3-phosphate 
dehydrogenase 
Catalyzes an important 
energy-yielding step in 
carbohydrate 
metabolism 
23411       
 







1029           CDKN2A                         
 
Cyclin dependent kinase inhibitor 
2A  
Cell cycle gene, 
tumor suppressor 
gene 
26277         
 
TINF2                             TERF1 interacting nuclear factor 2  Member of 
Shelterin complex, 
assembly regulator 
7014            TERF2                            Telomeric repeat binding factor 2  Member of 
Shelterin complex, 
negative regulator 
of telomere length, 
protective role of 
telomeres 
25913        
 
POT1                                Protection of telomeres 1  Regulating telomere 
length, protecting 
chromosome ends 




7015          TERT                               Telomerase reverse transcriptase  Enzyme with 
reverse transcriptase 
activity 
8658          TNKS                               Tankyrase  Telomere length 
regulation, vesicular 
traffic 
80351        TNKS2                             Tankyrase2  Telomere length 
regulation, vesicular 
traffic 
3178           HNRNPA1                       
 
Heterogeneous nuclear 
ribonucleoprotein A1  
Regulation of 
alternative splicing 
3185          HNRNPF                          
 
Heterogeneous nuclear 








3183          
 
HNRNPC                          Heterogeneous nuclear 








3181          
 
HNRNPA2B1                  Heterogeneous nuclear 
ribonucleoprotein 2B1  
mRNA metabolism 
and transport 
3182          
 
HNRNPAB                      Heterogeneous nuclear 





3184          HNRNPD                          Heterogeneous nuclear 











7520   XRCC5                              X-ray repair cross complementing 5 DNA double-strand 
break repair 
4683        NBN                                   Nibrin  DNA double-strand 






4361        MRE11                               MRE11 homolog, double strand 
break repair nuclease  
Telomere length 
maintenance, DNA 
2547        XRCC6                               X-ray repair cross complementing 6  DNA double-strand 
break repair, 
Transposition 
216         ALDH1A1                         Aldehyde dehydrogenase 1 family 
member A1  
Regulation of the 
metabolic responses 
to high-fat diet 
8854       ALDH1A2                         Aldehyde dehydrogenase 1 family 
member A2 
Synthesis of retinoic 








enzyme that uses 
retinal 
219        ALDH1B1                       Aldehyde dehydrogenase 1 family 












224       ALDH3A2                        Aldehyde dehydrogenase 3 family 




221      ALDH3B1                       Aldehyde dehydrogenase 3 family 




222       ALDH3B2                        Aldehyde dehydrogenase 3 family 















Figura 1. A (Stewart e Weinberg, 2006), B T-loop, D-loop and shelterin protein complex (TRF1, TRF2, TPP1, POT1, 






Figura 2. MicroRNA array profiling. (a, b) Clustergrams of 380 miRNAs in 3D S-ASCs and ASCs; the analysis 
showed 26 upregulated (14%) and 56 downregulated (25%) miRNAs; 46% were undetermined (Ct values were 
higher than 35), and no differences were reported for 15% miRNAs in S-ASCs versus ASCs. (c) The volcano plot is 
used for statistical analysis of miRNA arrays; the points above the line represent statistically significant miRNAs 
(left and right); p < 0.05, whereas those below line indicate no significant miRNAs. (d, e) Graphic representation of 










Figura 3. Expression level of miR‐142‐3p and stemness markers. (a) Summary diagram of microRNAs and 
messenger RNAs involved with stemness and early and late mesenchymal differentiation analyzed in the study. (b) 
Fold regulation of miR‐142‐3p and three Yamanaka’s factors (SOX2, NANOG, and OCT4).  miR‐191 and GAPDH 
were used as endogenous controls (c) Expression of miR‐142‐3p through digital PCR in 3D S‐ASCs  and ASCs. (d) 
Phase contrast; hematoxylin and eosin staining; nuclear SOX2, NANOG, and OCT4 through immunofluorescent 























































































Figura 4. Expression levels of microRNAs (miRNAs) and messenger RNAs (mRNAs) related to early and late 
mesenchymal differentiation. MiRNA and mRNA expressions in chondrogenic (a), adipogenic differentiation (b), 
and osteogenic (c) in S‐ASCs, ASCs, and S‐ ASCs differentiated cells after 28 days of in vitro differentiation. The 






























































Figura 5. MicroRNAs (miRNAs) analysis during long‐term in vitro culture. Relative miRNA expression after 1, 14, 
and 28 days in vitro culture in 3D S‐ASCs and ASCs, involved in stemness (a), early and late chondrogenic (b), 
adipogenic (c), and osteogenic differentiation (d). miR-191 was used as endogenous control. The error bars indicate 








Figura 6. Messenger RNA (mRNA) analysis during long‐term in vitro culture. Relative mRNA expressions after 1, 
14, and 28 days of in vitro culture in 3D S‐ASCs and ASCs, involved in stemness (a) and early and late chondrogenic 
(b), adipogenic (c), and osteogenic differentiation (d). GAPDH was used as endogenous control. The error bars 








Figura 7. Morphological analysis of cell culture 2D versus 3D. (A) Phase contrast images of SASCs-3D in ultra-low 
adherent surface, SASCs-3D in adherent condition SASCs-3D AD. and ASCs-2D. Scale bar = 50 μm. (B) Cell 
viability after 1, 14 and 28 days of in vitro culture. (C) Annexin V/7-AAD staining at 14 and 28 days of in vitro 





Figura 8. Comparative analysis of mRNAs expression on genes involved in stemness and aging-related processes. 
Relative gene expression fold change of SOX2, NANOG and POU5F1 in SASCs-3D and ASCs-2D at 14 days (A) 
and 28 days (B) of cell culture. SIRT1 and CDKN2A expression levels in SASCs-3D and ASCs-2D cells at 14 (C) 





































































Figura 9. Comparative evaluation of telomeric length and genes associated with telomere maintenance. Telomeric 
length quantification (T/S ratio) of SASCs-3D and ASCs-2D at 14 days (A) and 28 days (B) and mRNA expression 
analysis of 19 associated to Shelterin complex (C), RNA binding protein (E) and DNA repair (F) at 28 days of in 
vitro culture. Gene expression of TINF2, TERF2 and TERF2IP (D) in SASCs-3D and ASCs-2D at 14 days of cell 
culture. The error bars indicate SD (n = 3); ** p < 0.01, *** p < 0.001 
 
Figura 10. Comparative evaluation of oxidative stress genes. (A) ROS endogenous levels in SASCs-3D and ASCs-
2D at 14 and 28 days of in vitro culture. The graph represents the mean fluorescent intensity (MFI). (B) Histogram 
representation of lipid peroxidation in SASCs-3D and ASCs-2D at 14 and 28 days assessed by flow cytometry. 
Realtime PCR analysis of ALDH class 3 (C) and ALDH class 1 (D) isoenzymes in SASCs-3D and ASCs-2D at 28 
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Figura 11. Comparative evaluation of TGF-β1 expression. Relative gene expression fold change of TGF-β1 in 
SASCs-3D and ASCs-2D at 14 (A) and 28 days (B) of in vitro culture. Flow cytometry analysis of TGF-β1 
expression in SASCs-3D and ASCs-2D at 14 days (C) and 28 days (D) of in vitro culture. The error bars indicate SD 
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